BIO-TECHNE Corp — Director's Dealing 2019

Aug 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-08-07

Reporting Person: BAUMGARTNER ROBERT V (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-07	Common Stock	P	500	$191.06	Acquired	8726	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$70.35	2021-10-26	Common Stock (5000)	5000	Direct
Stock Options (Right to Buy)	$66.90	2022-10-24	Common Stock (5000)	5000	Direct
Stock Options (Right to Buy)	$87.39	2023-10-30	Common Stock (4000)	4000	Direct
Stock Options (Right to Buy)	$91.78	2024-10-30	Common Stock (4000)	4000	Direct
Stock Options (Right to Buy)	$87.34	2025-10-28	Common Stock (4260)	4260	Direct
Stock Options (Right to Buy)	$101.19	2026-10-26	Common Stock (3985)	3985	Direct
Stock Options (Right to Buy)	$125.05	2027-10-26	Common Stock (3125)	3125	Direct
Stock Options (Right to Buy)	$179.84	2028-10-25	Common Stock (1898)	1898	Direct

Footnotes

F1: This option vests on the earlier of the one year anniversary of the grant date (10/25/2019) or the date of Bio-Techne 2019 Annual Meeting of Shareholders.